Leptin Trial on Gut-Brain Axis in Alcohol Use Disorder Registered

A clinical trial involving leptin was listed on clinicaltrials.gov with an update dated October 29, 2026. The study, titled "Investigation of the Gut-Brain Axis in Alcohol Use Disorder," is registered under identifier NCT07902635. Its current status is not yet recruiting. The trial phase is listed as not applicable. No outcomes, results, or efficacy data have been reported at this stage. The registration indicates that the study is being set up but has not yet begun enrolling participants. Leptin remains an approved compound, and this trial record reflects a planned investigation rather than completed research. Further details, including enrollment criteria and timelines, may be added to the registry as the study progresses toward recruitment. Readers interested in tracking this trial can refer to the official registry entry for updates on status changes. For more background on leptin, including its approved uses and general profile, readers can consult the compound overview.